approach to skull base
DESCRIPTION
approaches to anterior cranial fossaTRANSCRIPT
Approach to Skull BaseTumors
Manohar BanceProfessor, Division of
Otolaryngology, Dept of SurgeryDalhousie University
Classification:
Where is it?• Intra-axial vs extra-axial (outside brain)• CPA vs Jugular Foramen Vs Petrous ApexImaging• T1 vs T2• Light up on contrast• Shape, boundaries• Sometimes CT findings
Quickly Getting BearingsIn bonePetrous Apex:Chol GranMucocoeleCholesteatoma(epidermoid)Chrondroma/ChondrosarcTG schwannMetastasis
In CPA:Vest SchwannMeningiomaEpidermoidArachnoid CystLipoma
In Jugular Foramen:Glomus, Vagus Schwannoma, Met
MRI Imaging Characteristics
BRIGHT T1
CG
BRIGHT T2
Acoustic (+C)Meningioma(+C)Lipoma (-C)
EpidermoidArachnoid Cyst
Cerebellopontine Angle
• Area of the lateral (quadrimenal) cisterncontaining CSF, arachnoid tissue, cranial nervesand their associated vessels.
• Borders– Medial – lateral surface of the brainstem– Lateral – petrous bone– Superior – middle cerebellar peduncle & cerebellum– Inferior – arachnoid tissue of lower cranial nerves– Posterior – cerbellar peduncle
Medial:Lat surfaceBrainstem
Lat:PetrousBone
Sup: Middle Cbllr Peduncleand Cbllm
Inf: Lower CN and arachnoid
Post:not shownCbllr peduncle
CPA
CPA tumors
• Vestibular Schwannoma: 70-90%• Meningioma: 5-10%• Epidermoids: 2-5%• Arachnoid Cysts: 1%• Others: Facial and TG Schwannoma,
Lipoma, ELS tumor, aneurysm AICA etc
AN Features•Centered on Porus Acousticus
•Acute angles to petrous bone
•Often involves the IAC
•Homogeneous enhancement
•No dural tail
•No calcifications
Meningioma Features•Arise from surface of petrous bone
•Obtuse angles to petrous bone
•Uncommonly involves the IAC
•Frequently with dural tail
•Calcifications common
Arachnoid Cyst
Main differential onT1 and T2: Epidermoid
Epidermoid brighton DWI and FLAIRACyst follows CSF
T1
T2
FLAIR
DWI
Treatment
Treatment for VS
• Observation• Surgery
– Translabrynthine– Retrosigmoid– Middle Fossa
• Radiotherapy– Conventional radiation therapy– Stereotactic radiosurgery
Choice of Surgical Approach
Hearing Preservation Wanted?
Large Tumor:Suboccipital
Yes
Small LateralTumor: Middle
Fossa
Any Size Tumor:Translabyrinthine
No
Large Tumor?Yes
No
SO
TL
TC/TO
MF
Views From Different Approaches
Trans-labyrinthine• Indications
– Non-serviceable hearing• Advantages:
– little cerebellar retraction– Good exposure of facial nerve laterally– Can do all size tumors
• Disadvantages:– Sacrifice hearing, slightly higher CSF leak rate
Middle Fossa• Indications
– Intracanallicular tumor (maybe 0.5cm into IAC)– Residual Hearing (50:50 or 70:30 rule)
• Contraindications– Large tumors– Older patients ( > 60 yrs. may have higher rate of bleeding or
stroke)
• Advantages:– Perhaps highest hearing preservation rate– Good access to lateral fundus
• Disadvantages:– Facial nerve first in line of exposure in IAC– Limited medial exposure– Risk of Seizure
Retrosigmoid• Indications
– Serviceable hearing– Any size tumor as long as not in lateral fundus only
• Contraindications– Lateral IAC tumor (cant get to fundus without risking hearing)
• Advantages– Good exposure superior-inferiorly– Familiar to most neurosurgeons
• Disadvantages– Cerebellar retraction– Limited access to lateral fundus
Observation
• Still relatively high chance of significanthearing loss, approx 40%
• Only about 30-50% of tumors requiretreatment
• Often used in elderly, medically unfit
Stereotactic Radiosurgery
• LINAC, Gamma Knife, Cyber-knife• Fractionated vs non-fractionated• Tumor control rates well over 90%• Risks:
– Tumor miss, hydrocephalus, facial pain, facialparalysis (under 5% and usually partial),malignant transformation
– Similar or increased risk of long term hearingloss to conservative treatment
Special Case: NF2
• Scan whole brain, not just IAC• Scan spine• Screen family• Counsel re family planning
Petrous Apex Masses
Petrous Apex MassesBeware petrous apex asymmetric pneumatization
Table 2. Petrous Apex Lesion Characteristics on MRI Scanning (Intensity Compared with Adjacent Brain)*
Lesion T1 Images T2 Images T1-Gadolinium
Cholesteatoma Hypo Hyper No enhancement
Cholesterol granuloma Hyper Markedly hyper No enhancement
Petrous apicitis Hypo Hyper Rim enhancement
Effusion Hypo Hyper Mucosal enhancement
Bone marrow asymmetry Hyper Hypo No enhancement
Neoplasia Hypo Hyper Enhancing
From Jackler RK and Parker D: The radiographic differential diagnosis of petrousapex lesions. AJO 1992;13:561-574
Approaches to Petrous Apex
• Translabyrinthine, Transcochlear/otic• Infracochlear• Infralabyrinthine , retrolabyrinthine and
other perilabyrinthine approaches• Transsphenoid• Middle Fossa• Partial labyrinthectomy
TranspenoidalTransphenoidal
Infralab
TL or TC
Infracochlear
Jugulotympanic Paragangliomas
• 2nd most common temporal bone tumor ( after AN)• 4:1 female to male ratio• Median age of presentation 50-60 yrs• No ethnic or racial predeliction• Sporadic and familial forms ( 25 – 50% multicentricity)• Functional secretion about 1-3%• Malignancy rate < 5%
Imaging: salt and pepper pattern
Jugulotympanic ParagangliomasClassification
• Glasscock-Jackson Classification– I. Small tumor involving jugular bulb, middle ear, and
mastoid– II. Tumor extending under internal auditory canal; may
have intracranial extension (ICE)– III. Tumor extending into petrous apex; may have ICE– Tumor extending beyond petrous apex into clivus or
infratemporal fossa; may have ICE
• Fisch Classification
Systemic Considerations
• Association with MEN IIA, MEN IIB, VHL• Paraganglioma neuropeptides
– Norepinephrine, serotonin, vasoactiveintestinal peptide, neuron specific enolase
• 1-3% functional• Symptoms
– HA, palpitations, flushing, perspiration
Fisch Type A approach
Treatment
• Surgical: Fisch Type A or extendedmastoidectomy– Mobilize facial nerve anteriorly– Isolate tumor between jugular vein in neck
and the sigmoid sinus• Stereotactic or conventional radiotherapy• Observation
Summary• Diagnosis:
– Where is it?– What are its imaging characteristics?
• Treatment similar for all common ones:– Surgery– Watch– Radiation (except epidermoid)
• Don’t forget about rehabilitation afterwards